AEON vs AFL · P/E 0.0, $8.6M cap vs P/E 14, rev $4.12B
AEON Biopharma, Inc. (AEON) versus Aflac Incorporated (AFL) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
AEON does not have a complete income-statement cache yet.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Not investment advice. Open the AEON and AFL stock pages for the full models.
Not investment advice.